| Date Checked | 2025-12-21 23:39:19 |
|---|---|
| Graham Number | (PB)50.20 vs (PE)53.03 |
| Over / Under Value Percentage | 139.11% vs 133.47% |
| Dividend Yield | 2.53% |
| Dividend Date | 2025-12-30 |
| Symbol | GILD |
| AssetType | Common Stock |
| Name | Gilead Sciences Inc |
| Description | Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering research and development of antiviral therapies aimed at treating infectious diseases, most notably HIV and hepatitis. The company’s industry-defining products, such as Harvoni and Sovaldi, have transformed treatment paradigms for chronic hepatitis C, underscoring Gilead's commitment to innovation and excellence in healthcare. With a growing and diversified therapeutic portfolio, Gilead is dedicated to addressing critical unmet medical needs, solidifying its role as a key player in enhancing global health outcomes and patient care. |
| CIK | 882095 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404 |
| OfficialSite | https://www.gilead.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 155100856000 |
| EBITDA | 14136001000 |
| PERatio | 19.35 |
| PEGRatio | 0.227 |
| BookValue | 17.34 |
| DividendPerShare | 3.14 |
| EPS | 6.46 |
| RevenuePerShareTTM | 23.35 |
| ProfitMargin | 0.279 |
| OperatingMarginTTM | 0.452 |
| ReturnOnAssetsTTM | 0.126 |
| ReturnOnEquityTTM | 0.407 |
| RevenueTTM | 29087001000 |
| GrossProfitTTM | 22896001000 |
| DilutedEPSTTM | 6.46 |
| QuarterlyEarningsGrowthYOY | 1.43 |
| QuarterlyRevenueGrowthYOY | 0.03 |
| AnalystTargetPrice | 130.63 |
| AnalystRatingStrongBuy | 5 |
| AnalystRatingBuy | 16 |
| AnalystRatingHold | 8 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 19.35 |
| ForwardPE | 14.14 |
| PriceToSalesRatioTTM | 5.33 |
| PriceToBookRatio | 7.16 |
| EVToRevenue | 5.91 |
| EVToEBITDA | 12.57 |
| Beta | 0.334 |
| 52WeekHigh | 128.7 |
| 52WeekLow | 86.73 |
| 50DayMovingAverage | 120.04 |
| 200DayMovingAverage | 112.72 |
| SharesOutstanding | 1240680000 |
| SharesFloat | 1238037000 |
| PercentInsiders | 0.096 |
| PercentInstitutions | 91.368 |
| ExDividendDate | 2025-12-15 |
| naga | 1 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:39:19 |
| fresh | 1 |